

1,401,923 filings since 2004 · latest accepted Nov 3, 2026, 5:27 PM ET
Priority items usually mark a change in credit, accounting integrity, control or listing status: 1.02 Agreement terminated, 1.03 Bankruptcy, 1.05 Cybersecurity incident, 2.04 Debt acceleration, 2.05 Restructuring costs, 2.06 Impairment, 3.01 Delisting notice, 4.01 Auditor change, 4.02 Non-reliance (restatement), 5.01 Change in control.
| Filed | Company | Items | Filing |
|---|---|---|---|
Oct 16, 2026 accepted 9:00 PM ET | PMCBPharmaCyte Biotech, Inc. | 4.01Auditor change | DocumentSEC ↗ |
Dec 5, 2025 accepted 10:00 PM ET | PMCBPharmaCyte Biotech, Inc. | 3.01Delisting notice | Document |
Source: SEC EDGAR. Same-day filings appear within minutes and are re-checked against SEC's nightly index. Tickers are current listings, so a company's older filings show its ticker today.
Feb 26, 2025 accepted 6:57 PM ET | PMCBPharmaCyte Biotech, Inc. | 4.01Auditor change | DocumentSEC ↗ |
Nov 9, 2023 accepted 10:25 PM ET | PMCBPharmaCyte Biotech, Inc. | 4.01Auditor change | DocumentSEC ↗ |
Aug 4, 2023 accepted 8:01 PM ET | PMCBPharmaCyte Biotech, Inc. | 4.01Auditor change | DocumentSEC ↗ |
Mar 1, 2022 accepted 1:50 AM ET | PMCBPharmaCyte Biotech, Inc. | 3.01Delisting notice | DocumentSEC ↗ |
Feb 17, 2022 accepted 10:14 PM ET | PMCBPharmaCyte Biotech, Inc. | 3.01Delisting notice | DocumentSEC ↗ |
Feb 22, 2018 accepted 9:18 PM ET | PMCBPharmaCyte Biotech, Inc. | 1.01Material agreement1.02Agreement terminated | DocumentSEC ↗ |
Dec 31, 2015 accepted 2:23 PM ET | PMCBPharmaCyte Biotech, Inc. | 4.02Non-reliance (restatement)5.02Officer / director change | DocumentSEC ↗ |
Nov 2, 2015 accepted 9:14 PM ET | PMCBPharmaCyte Biotech, Inc. | 4.01Auditor change | DocumentSEC ↗ |
May 28, 2015 accepted 9:32 PM ET | PMCBPharmaCyte Biotech, Inc. | 4.01Auditor change | DocumentSEC ↗ |
May 29, 2014 accepted 10:22 PM ET | PMCBPharmaCyte Biotech, Inc. | 1.01Material agreement1.02Agreement terminated | DocumentSEC ↗ |
Feb 29, 2012 accepted 11:17 PM ET | PMCBPharmaCyte Biotech, Inc. | 8-K/A 4.01Auditor change | DocumentSEC ↗ |
Feb 15, 2012 accepted 7:44 PM ET | PMCBPharmaCyte Biotech, Inc. | 4.01Auditor change | DocumentSEC ↗ |
Jul 25, 2011 accepted 2:43 PM ET | PMCBPharmaCyte Biotech, Inc. | 3.01Delisting notice | DocumentSEC ↗ |
Apr 26, 2011 accepted 8:43 PM ET | PMCBPharmaCyte Biotech, Inc. | 8-K/A 4.02Non-reliance (restatement) | DocumentSEC ↗ |
Mar 2, 2011 accepted 8:36 PM ET | PMCBPharmaCyte Biotech, Inc. | 8-K/A 4.02Non-reliance (restatement) | DocumentSEC ↗ |
Jan 31, 2011 accepted 4:58 PM ET | PMCBPharmaCyte Biotech, Inc. | 4.02Non-reliance (restatement) | DocumentSEC ↗ |
Jan 14, 2011 accepted 9:19 PM ET | PMCBPharmaCyte Biotech, Inc. | 8-K/A 3.01Delisting notice4.02Non-reliance (restatement) | DocumentSEC ↗ |
Sep 15, 2010 accepted 6:46 PM ET | PMCBPharmaCyte Biotech, Inc. | 3.01Delisting notice4.02Non-reliance (restatement) | DocumentSEC ↗ |
Mar 29, 2010 accepted 10:03 PM ET | PMCBPharmaCyte Biotech, Inc. | 8-K/A 4.01Auditor change | DocumentSEC ↗ |
Mar 9, 2010 accepted 4:57 PM ET | PMCBPharmaCyte Biotech, Inc. | 4.01Auditor change | DocumentSEC ↗ |
Mar 26, 2009 accepted 7:46 PM ET | PMCBPharmaCyte Biotech, Inc. | 5.01Change in control5.02Officer / director change5.03Bylaws / fiscal year | DocumentSEC ↗ |
Jul 2, 2007 accepted 8:09 PM ET | PMCBPharmaCyte Biotech, Inc. | 8-K/A 4.01Auditor change | DocumentSEC ↗ |
Jun 21, 2007 accepted 2:14 PM ET | PMCBPharmaCyte Biotech, Inc. | 4.01Auditor change | DocumentSEC ↗ |